Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 9, Issue 1, 2006, Pages 62-67

  Hu, C K ^a   McCall, S ^a   Madden, J ^a   Huang, H ^a   Clough, R ^a   Jirtle, R L ^a   Anscher, M S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Genetics; Loss of heterozygosity; Mannose 6 phosphate insulin like growth factor 2 receptor; Mutations; Prostate cancer

Indexed keywords

SOMATOMEDIN B RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FOLLOW UP; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRON; LASER CAPTURE MICRODISSECTION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE;

AGED; DISEASE PROGRESSION; DNA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LASERS; LOSS OF HETEROZYGOSITY; MALE; MICRODISSECTION; MIDDLE AGED; PROSTATE; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECEPTOR, IGF TYPE 2;

EID: 33644914726     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500842     Document Type: Article

References (28)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M. Cancer Statistics, 2003. CA Cancer J Clin 2003; 53: 5-26.
2. Kornfeld S. Structure and function of the mannose 6-phosphate/ insulin-like growth factor II receptors. Ann Rev Biochem 1992; 61: 307-330.
3. De Souza AT, Yamada T, Mills JJ, Jirtle RL. Imprinted genes in liver carcinogenesis. FASEB J 1997; 11: 60-67.
4. Jirtle RL. Genomic imprinting and cancer. Exp Cell Res 1999; 248: 18-24.
5. DeSouza AT, Hankins GR, Washington MK, Fine RL, Orton TC, Jirtle RL. Frequent loss of heterozygocity on 6q at the mannose-6-phosphate/ insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene 1995; 10: 1725-1729.
6. DeSouza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL. M6P/IGF2r gene is mutated in human hepatocellular carcinomas with LOH. Nat Genet 1995; 11: 447-449.
7. Hankins G, De Souza A, Bentley R, Patel M, Marks J, Iglehart J et al. M6P/IGF2 receptor: A candidate breast tumor suppressor gene. Oncogene 1996; 12: 2003-2009.
8. Yamada T, De Souza AT, Finkelstein S, Jirtle RL. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci USA 1997; 94: 10351-10355.
9. Jamieson TA, Brizel DM, Killian JK, Oka Y, Jang HS, Fu X et al. M6P/ IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis. BMC Cancer 2003; 3: 4.
10. Dennis P, Rifkin D. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/ insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 1991; 88: 580-584.
11. Korner C, Nurnberg B, Uhde M, Braulke T. Mannose 6-phosphate/ insulin-like growth factor II receptor fails to interact with G-proteins. Analysis of mutant cytoplasmic receptor domains. J Biol Chem 1995; 270: 287-295.
12. Czech MP. Signal transmission by the insulin-like growth factors. Cell 1989; 59: 235-238.
13. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A et al. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 1999; 19: 3278-3288.
14. Jirtle R. Genomic imprinting and cancer. Exp Cell Res 1999; 248: 18-24.
15. Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM et al. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet 1996; 14: 255-257.
16. Ouyang H, Shiwaku HO, Hagiwara H, Miura K, Abe T, Kato Y et al. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res 1997; 57: 1851-1854.
17. Leung SY, Chan TL, Chung LP, Chan AS, Fan YW, Hung KN et al. Microsatellite instability and mutation of DNA mismatch repair genes in gliomas. Am J Pathol 1998; 153: 1181-1188.
18. Kong FM, Anscher MS, Washington MK, Killian JK, Jirtle RL. M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Oncogene 2000; 19: 1572-1578.
19. Chappell SA, Walsh T, Walker RA, Shaw JA. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas. Br J Cancer 1997; 76: 1558-1561.
20. Jamieson TA, Brizel DM, Killian JK, Oka Y, Jang HS, Fu X et al. M6P/ IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis. BMC Cancer 2003; 3: 4.
21. Wikstrom P, Damber J, Bergh A. Role of transforming growth factor-beta1 in prostate cancer. Microsc Res Tech 2001; 52: 411-419.
22. Killian JK, Oka Y, Jang HS, Fu X, Waterland RA, Sohda T et al. Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations. Hum Mutat 2001; 18: 25-31.
23. Oka Y, Waterland RA, Killian JK, Nolan CM, Jang HS, Tohara K et al. M6P/ IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan. Hepatology 2002; 35: 1153-1163.
24. Killian JK, Jirtle RL. Genomic structure of the human M6P/IGF2 receptor. Mamm Genome 1999; 10: 74-77.
25. Leboulleux S, Gaston V, Boulle N, Le Bouc Y, Gicquel C. Loss of heterozygosity at the mannose 6-phosphate/insulin-like growth factor 2 receptor locus: A frequent but late event in adrenocortical tumorigenesis. Eur J Endocrinol 2001; 144: 163-168.
26. Nupponen NN, Kakkola L, Koivisto P, Visakorpi T. Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am J Pathol 1998; 153: 141-148.
27. Wang Z, Lai FM, Zhang J. [Analysis of loss of heterozygosity on chromosome 6 in human prostate carcinoma and prostatic intraepithelial neoplasia]. Zhonghua Bing Li Xue Za Zhi 2001; 30: 414-417.
28. O'Shaughnessy JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, Fabian CJ et al. Treatment and prevention of intraepithelial neoplasia: An important target for accelerated new agent development. Clin Cancer Res 2002; 8: 314-346.